Cargando…

Ir-6: A Novel Iridium (III) Organometallic Derivative for Inhibition of Human Platelet Activation

Platelet activation has been reported to play a major role in arterial thrombosis, cancer metastasis, and progression. Recently, we developed a novel Ir(III)-based compound, [Ir(Cp(∗))1-(2-pyridyl)-3-(4-dimethylaminophenyl)imidazo[1,5-a]pyridine Cl]BF(4) or Ir-6 and assessed its effectiveness as an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shyu, Ren-Shi, Khamrang, Themmila, Sheu, Joen-Rong, Hsia, Chih-Wei, Velusamy, Marappan, Hsia, Chih-Hsuan, Chou, Duen-Suey, Chang, Chao-Chien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954965/ https://www.ncbi.nlm.nih.gov/pubmed/29853830 http://dx.doi.org/10.1155/2018/8291393

Ejemplares similares

Novel iridium (III)-derived organometallic compound for the inhibition of human platelet activation
por: Shyu, Kou-Gi, et al.
Publicado: (2018)

Novel iridium (III)-derived organometallic compound for the inhibition of human platelet activation
por: Shyu, Kou-Gi, et al.
Publicado: (2019)

New Therapeutic Agent against Arterial Thrombosis: An Iridium(III)-Derived Organometallic Compound
por: Hsia, Chih-Wei, et al.
Publicado: (2017)

A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies
por: Hsia, Chih-Hsuan, et al.
Publicado: (2017)

Author Correction: A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies
por: Hsia, Chih-Hsuan, et al.
Publicado: (2020)

Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets
por: Hsia, Chih-Hsuan, et al.
Publicado: (2018)

Structure–Activity Relationship Study of Newly Synthesized Iridium-III Complexes as Potential Series for Treating Thrombotic Diseases
por: Yang, Chih-Hao, et al.
Publicado: (2018)

Esculetin, a Coumarin Derivative, Prevents Thrombosis: Inhibitory Signaling on PLCγ2–PKC–AKT Activation in Human Platelets
por: Hsia, Chih-Wei, et al.
Publicado: (2019)

Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling
por: Khamrang, Themmila, et al.
Publicado: (2017)

Novel Therapeutic Agent against Platelet Activation In Vitro and Arterial Thrombosis In Vivo by Morin Hydrate
por: Hsia, Chih-Wei, et al.
Publicado: (2018)

Possible Molecular Targets of Novel Ruthenium Complexes in Antiplatelet Therapy
por: Jayakumar, Thanasekaran, et al.
Publicado: (2018)

Synthetic Ruthenium Complex TQ-6 Potently Recovers Cerebral Ischemic Stroke: Attenuation of Microglia and Platelet Activation
por: Hsia, Chih-Hsuan, et al.
Publicado: (2020)

Modulation of human platelet activation and in vivo vascular thrombosis by columbianadin: regulation by integrin α(IIb)β(3) inside-out but not outside-in signals
por: Hou, Shaw-Min, et al.
Publicado: (2020)

Suppression of Human Platelet Activation via Integrin α(IIb)β(3) Outside-In Independent Signal and Reduction of the Mortality in Pulmonary Thrombosis by Auraptene
por: Hsia, Chih-Wei, et al.
Publicado: (2019)

Mechanisms of Ascorbyl Radical Formation in Human Platelet-Rich Plasma
por: Shyu, Kou-Gi, et al.
Publicado: (2014)

Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen–integrin α(II) (b)β(3) binding in human platelets
por: Hsia, Chih‐Hsuan, et al.
Publicado: (2018)

Mechanisms of TQ-6, a Novel Ruthenium-Derivative Compound, against Lipopolysaccharide-Induced In Vitro Macrophage Activation and Liver Injury in Experimental Mice: The Crucial Role of p38 MAPK and NF-κB Signaling
por: Hsia, Chih-Hsuan, et al.
Publicado: (2018)

Mechanisms of glabridin inhibition of integrin α(IIb)β(3) inside-out signals and NF-κB activation in human platelets
por: Huang, Wei-Chieh, et al.
Publicado: (2023)

Regulation of Human Platelet Activation and Prevention of Arterial Thrombosis in Mice by Auraptene through Inhibition of NF-κB Pathway
por: Hsia, Chih-Wei, et al.
Publicado: (2020)

A novel indication of platonin, a therapeutic immunomodulating medicine, on neuroprotection against ischemic stroke in mice
por: Sheu, Joen-Rong, et al.
Publicado: (2017)

Author Correction: A novel indication of platonin, a therapeutic immunomodulating medicine, on neuroprotection against ischemic stroke in mice
por: Sheu, Joen-Rong, et al.
Publicado: (2020)

Myricetin as a promising inhibitor of platelet fibrinogen receptor in humans
por: Chang, Yi, et al.
Publicado: (2023)

IoT-enabled dye-sensitized solar cells: an effective embedded tool for monitoring the outdoor device performance
por: Khamrang, Themmila, et al.
Publicado: (2020)

Internet of Things-Enabled Aggregation-Induced Emission Probe for Cu(2+) Ions: Comprehensive Investigations and Three-Dimensional Printed Portable Device Design
por: Kathiravan, Arunkumar, et al.
Publicado: (2020)

Glabridin, a Bioactive Flavonoid from Licorice, Effectively Inhibits Platelet Activation in Humans and Mice
por: Chung, Chi-Li, et al.
Publicado: (2022)

Innovative Targeting Strategies in Drug Therapy for Inflammatory Diseases: Mechanistic Approaches
por: Chou, Duen-Suey, et al.
Publicado: (2015)

Novel Bioactivity of Ellagic Acid in Inhibiting Human Platelet Activation
por: Chang, Yi, et al.
Publicado: (2013)

The Antithrombotic Agent Pterostilbene Interferes with Integrin α(IIb)β(3)-Mediated Inside-Out and Outside-In Signals in Human Platelets
por: Huang, Wei-Chieh, et al.
Publicado: (2021)

Comparison of free radical formation induced by baicalein and pentamethyl-hydroxychromane in human promyelocytic leukemia cells using electron spin resonance
por: Huang, Yung-Kai, et al.
Publicado: (2014)

Xanthohumol, a Prenylated Flavonoid from Hops (Humulus lupulus), Prevents Platelet Activation in Human Platelets
por: Lee, Ye-Ming, et al.
Publicado: (2012)

Decreased Human Platelet Activation and Mouse Pulmonary Thrombosis by Rutaecarpine and Comparison of the Relative Effectiveness with BAY11-7082: Crucial Signals of p38-NF-κB
por: Huang, Wei-Chieh, et al.
Publicado: (2022)

Cyclic nucleotides and mitogen-activated protein kinases: regulation of simvastatin in platelet activation
por: Lee, Ye-Ming, et al.
Publicado: (2010)

Targeting MAPK/NF-κB Pathways in Anti-Inflammatory Potential of Rutaecarpine: Impact on Src/FAK-Mediated Macrophage Migration
por: Jayakumar, Thanasekaran, et al.
Publicado: (2021)

Neuroprotection by the Traditional Chinese Medicine, Tao-Hong-Si-Wu-Tang, against Middle Cerebral Artery Occlusion-Induced Cerebral Ischemia in Rats
por: Wu, Chih-Jen, et al.
Publicado: (2011)

Effect of Antrodia camphorata on Inflammatory Arterial Thrombosis-Mediated Platelet Activation: The Pivotal Role of Protein Kinase C
por: Lu, Wan-Jung, et al.
Publicado: (2014)

Inhibitory Effects of Ketamine on Lipopolysaccharide-Induced Microglial Activation
por: Chang, Yi, et al.
Publicado: (2009)

Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways
por: Hsia, Chih-Hsuan, et al.
Publicado: (2021)

Corrigendum to “Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways”
por: Hsia, Chih-Hsuan, et al.
Publicado: (2022)

Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats
por: Chang, Yi, et al.
Publicado: (2009)

Activation of Nrf2 by Esculetin Mitigates Inflammatory Responses through Suppression of NF-κB Signaling Cascade in RAW 264.7 Cells
por: Jayakumar, Thanasekaran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5j4e58b7u3trreatp5vd1h1psu